Your browser doesn't support javascript.
loading
Plain language summary of the MAIA study of daratumumab plus lenalidomide and dexamethasone for the treatment of people with newly diagnosed multiple myeloma.
Facon, Thierry; Kumar, Shaji K; Plesner, Torben; Orlowski, Robert Z; Moreau, Philippe; Bahlis, Nizar; Basu, Supratik; Nahi, Hareth; Hulin, Cyrille; Quach, Hang; Goldschmidt, Hartmut; Perrot, Aurore; Weisel, Katja; Raje, Noopur; Macro, Margaret; Frenzel, Laurent; Leleu, Xavier; Wang, Jianping; Rampelbergh, Rian Van; Uhlar, Clarissa M; Vermeulen, Jessica; Duran, Joana; Borgsten, Fredrik; Usmani, Saad Z.
Afiliación
  • Facon T; University of Lille, Centre Hospitalier Universitaire de Lille, Service des Maladies du Sang, Lille, France; Académie Nationale de Médecine, Paris, France.
  • Kumar SK; Department of Hematology, Mayo Clinic Rochester, Rochester, MN, United States.
  • Plesner T; Vejle, Hospital & University of Southern Denmark, Vejle, Denmark.
  • Orlowski RZ; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Moreau P; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Bahlis N; Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada.
  • Basu S; The Royal Wolverhampton NHS Trust & University of Wolverhampton, Wolverhampton, United Kingdom.
  • Nahi H; Karolinska Institute, Department of Medicine, Division of Hematology, Karolinska University Hospital at Huddinge, Stockholm, Sweden.
  • Hulin C; Department of Hematology, Hôpital Haut Lévêque, University Hospital, Pessac, France.
  • Quach H; University of Melbourne, St Vincent's Hospital, Melbourne, VIC, Australia.
  • Goldschmidt H; University Hospital Heidelberg, Internal Medicine V & National Center for Tumor Diseases, Heidelberg, Germany.
  • Perrot A; Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse - Oncopole, Université de Toulouse, Université Paul Sabatier, Service d'Hématologie, Toulouse, France.
  • Weisel K; Department of Oncology, Hematology & Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Raje N; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA, United States.
  • Macro M; Centre Hospitalier Universitaire de Caen, Caen, France.
  • Frenzel L; Department of Clinical Haematology, Hopital Necker-Enfants Malades, Paris, France.
  • Leleu X; Centre Hospitalier Universitaire de Poitiers, Hôpital la Milétrie, Poitiers, France.
  • Wang J; Janssen Research & Development, Raritan, NJ, United States.
  • Rampelbergh RV; Janssen Research & Development, Beerse, Belgium.
  • Uhlar CM; Janssen Research & Development, Spring House, PA, United States.
  • Vermeulen J; Janssen Research & Development, Leiden, Netherlands.
  • Duran J; Janssen Research & Development, Raritan, NJ, United States.
  • Borgsten F; Janssen Research & Development, Bridgewater, NJ, United States.
  • Usmani SZ; Levine Cancer Institute/Atrium Health, Charlotte, NC, United States.
Future Oncol ; 19(13): 887-895, 2023 Apr.
Article en En | MEDLINE | ID: mdl-37212642
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Humans Idioma: En Revista: Future Oncol Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Humans Idioma: En Revista: Future Oncol Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido